Progress in histopathologic and pathogenetic research in a retinitis pigmentosa model
- PMID: 25671641
- DOI: 10.14670/HH-11-596
Progress in histopathologic and pathogenetic research in a retinitis pigmentosa model
Abstract
Retinitis pigmentosa is a major cause of visual impairment and blindness, affecting millions of people worldwide. The mechanisms of and effective treatments for the disease, however, remain to be further investigated. The Royal College of Surgeons rat is one of the most widely used animal models for the study of retinal degeneration diseases. The mutation in the mer tyrosine kinase proto-oncogene of this model leads to deficient phagocytosis in the retinal pigment epithelium cells and the accumulation of photoreceptor out segments in the subretinal space, ultimately resulting in retinal degeneration. The retina begins to change as early as 17 days after birth and becomes gradually thinner with the death and remodeling of cells and blood vessels. Retinal cell apoptosis plays a dominant role in this degeneration, with some cells being activated by the secondary alterations of the retinal neurotransmitter and other related factors.
Similar articles
-
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.Gene Ther. 2005 Apr;12(8):694-701. doi: 10.1038/sj.gt.3302460. Gene Ther. 2005. PMID: 15660111
-
Evaluation of inner retinal structure in the aged RCS rat.Adv Exp Med Biol. 2003;533:181-8. doi: 10.1007/978-1-4615-0067-4_23. Adv Exp Med Biol. 2003. PMID: 15180263 No abstract available.
-
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.Hum Gene Ther Clin Dev. 2013 Mar;24(1):23-8. doi: 10.1089/humc.2013.037. Epub 2013 Apr 3. Hum Gene Ther Clin Dev. 2013. PMID: 23692380 Free PMC article.
-
Histopathology of the human retina in retinitis pigmentosa.Prog Retin Eye Res. 1998 Apr;17(2):175-205. doi: 10.1016/s1350-9462(97)00012-8. Prog Retin Eye Res. 1998. PMID: 9695792 Review.
-
Retinal degeneration and local oxygen metabolism.Exp Eye Res. 2005 Jun;80(6):745-51. doi: 10.1016/j.exer.2005.01.018. Exp Eye Res. 2005. PMID: 15939030 Review.
Cited by
-
Changes in intrinsic excitability of ganglion cells in degenerated retinas of RCS rats.Int J Ophthalmol. 2018 May 18;11(5):756-765. doi: 10.18240/ijo.2018.05.07. eCollection 2018. Int J Ophthalmol. 2018. PMID: 29862172 Free PMC article.
-
Activation of liver X receptor delayed the retinal degeneration of rd1 mice through modulation of the immunological function of glia.Oncotarget. 2017 May 9;8(19):32068-32082. doi: 10.18632/oncotarget.16643. Oncotarget. 2017. PMID: 28404878 Free PMC article.
-
Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.Stem Cell Res Ther. 2020 Aug 12;11(1):353. doi: 10.1186/s13287-020-01870-w. Stem Cell Res Ther. 2020. PMID: 32787913 Free PMC article. Clinical Trial.
-
Clinical Impact of Spontaneous Hyperactivity in Degenerating Retinas: Significance for Diagnosis, Symptoms, and Treatment.Front Cell Neurosci. 2018 Sep 10;12:298. doi: 10.3389/fncel.2018.00298. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30250425 Free PMC article.
-
Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.Stem Cell Res Ther. 2020 Jan 13;11(1):25. doi: 10.1186/s13287-020-1549-6. Stem Cell Res Ther. 2020. PMID: 31931872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous